Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.96%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$250M
Cap. Flow %
-5.27%
Top 10 Hldgs %
49.5%
Holding
1,224
New
10
Increased
9
Reduced
12
Closed
13

Sector Composition

1 Real Estate 58.35%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DCPH
1026
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12K ﹤0.01%
302
ICPT
1027
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
185
ARNA
1028
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12K ﹤0.01%
283
MYOK
1029
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$12K ﹤0.01%
261
ALEC icon
1030
Alector
ALEC
$279M
$11K ﹤0.01%
438
APLS icon
1031
Apellis Pharmaceuticals
APLS
$3.4B
$11K ﹤0.01%
419
AXSM icon
1032
Axsome Therapeutics
AXSM
$6.45B
$11K ﹤0.01%
195
KRTX
1033
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11K ﹤0.01%
147
PRNB
1034
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$11K ﹤0.01%
185
DNLI icon
1035
Denali Therapeutics
DNLI
$2.27B
$10K ﹤0.01%
587
KB icon
1036
KB Financial Group
KB
$28.3B
$10K ﹤0.01%
350
XNCR icon
1037
Xencor
XNCR
$600M
$10K ﹤0.01%
320
EIDX
1038
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10K ﹤0.01%
212
ARVN icon
1039
Arvinas
ARVN
$583M
$9K ﹤0.01%
220
AUPH icon
1040
Aurinia Pharmaceuticals
AUPH
$1.62B
$9K ﹤0.01%
596
FATE icon
1041
Fate Therapeutics
FATE
$111M
$9K ﹤0.01%
410
IRWD icon
1042
Ironwood Pharmaceuticals
IRWD
$184M
$9K ﹤0.01%
885
TPTX
1043
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9K ﹤0.01%
202
EPZM
1044
DELISTED
Epizyme, Inc
EPZM
$9K ﹤0.01%
571
AMRN
1045
Amarin Corp
AMRN
$306M
$8K ﹤0.01%
100
CLPR
1046
Clipper Realty
CLPR
$71.4M
$8K ﹤0.01%
1,500
GLPG icon
1047
Galapagos
GLPG
$2.21B
$8K ﹤0.01%
40
INSM icon
1048
Insmed
INSM
$31B
$8K ﹤0.01%
504
PCRX icon
1049
Pacira BioSciences
PCRX
$1.2B
$8K ﹤0.01%
236
SAGE
1050
DELISTED
Sage Therapeutics
SAGE
$8K ﹤0.01%
292